EU GMP Annex 1 Revision Could Require Firms to Modify or Replace Cleanrooms
• By Joanne S. Eglovitch
Cap crimping provision draws fire as U.S. drug makers worry that EU Annex 1 revision could force expensive cleanroom modifications, even as they join EU manufacturers in applauding the revision's relaxation of requirements for particulate control during the manufacture of sterile drug products
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
